AI powered growth IQVIA leverages Healthcare-grade AI, advanced analytics and connected intelligence to deliver insights and services across clinical research, commercial insights, and healthcare data, indicating opportunities to upsell AI-driven analytics, data privacy compliant solutions, and end-to-end study optimization platforms.

Scale and reach With over 88,000 employees in more than 100 countries, IQVIA has the global footprint to support multinational trials, market access strategies, and payer collaborations, suggesting sales opportunities in global clinical development support, harmonized data services, and cross-border regulatory analytics.

Financial momentum Large revenue footprint and recent debt financing activity (senior notes) point to ongoing capital programs and potential needs for scalable data infrastructure, managed services, and performance-based pricing models tied to accelerated trial timelines and cost savings.

Privacy first IQVIA highlights strong patient privacy protections and privacy-enhancing technologies, opening doors for compliant data partnerships, risk management solutions, and privacy-by-design consulting for biotech and pharma clients.

Predictive clinical The launch of Predictive Clinical Development showcases AI-driven efficiency gains to bring therapies to market faster, presenting a clear opportunity to sell AI-powered trial design, site optimization, and real-time analytics that reduce delays and increase trial success rates.